Hepatitis C in homeless people: reaching a hard-to-reach population.  Alfranca R, Salvans M, López C, Giralt C, Ramírez M, Calvo F.  Rev Esp Enferm Dig. 2021 Jan 26. doi: 10.17235/reed.2021.7737/2020. Epub ahead of print. PMID: 3349461...

Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol.  Sharhani A, Jorjoran Shushtari Z, Rahmani A, Armoon B, Noroozi M, Ahounbar E, Karimi SE, Higgs P.  BMJ Open. 2021 Jan 15;11(1):e04148...

A Call to Action: HCV Treatment of People Who Inject Drugs in the United States.  Norton BL, Litwin AH.  Clin Infect Dis. 2020 May 23;70(11):2366-2368. doi: 10.1093/cid/ciz701. PMID: 31513706; PMCID: PMC7390356. https://www.ncbi.nlm.n...

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.  Rajabi, A., Sharafi, H. & Alavian, S.M.  Harm Reduct J 18, 12 (2021)...

Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens.  Tayyab GUN, Rasool S, Nasir B, Rubi G, Abou-Samra AB, Butt AA.  BMC Gastroenterol. 2020 Apr 6;20(1):93....

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States.  Yang M, Parikh ND, Liu H, Wu E, Rao H, Feng B, Lin A, Wei L, Lok AS. Sci Rep. 2020 Dec 1;10(1):20922. doi: 10.1038/s41598-0...